AI Insight
This article presents a precision prevention and early detection (PPED) framework for cancer control that personalizes interventions based on individual risk profiles. Currently, only 13% of cancers are detected through guideline-based screening, and 20-50% are first diagnosed in emergency departments, despite stage at diagnosis being the strongest predictor of survival. The PPED approach addresses who is at elevated risk, what preventive interventions are appropriate, when and at what intensity they should be applied, and how and where services should be delivered, emphasizing both escalation of care for high-risk individuals and de-escalation for low-risk populations.
Why it matters
This framework could significantly improve cancer outcomes by shifting detection to earlier, more treatable stages through risk-stratified screening approaches. It has potential to reduce healthcare costs and patient burden by avoiding unnecessary interventions in low-risk individuals while intensifying prevention efforts for those at higher risk.
Understand the Science
Stage at diagnosis remains the strongest determinant of cancer survival, yet only 13% of cancers are detected through guideline-based screening, and 20–50% first present in an emergency department. Precision prevention and early detection (PPED) tailors cancer control by asking who is at elevated risk of developing cancer, what preventive intervention is appropriate, when should intervention be applied and at what intensity, and how and where preventive services should be delivered. De-escalation of preventive interventions in low-risk individuals is as important as preventive care escalation in high-risk individuals.